Literature DB >> 12017388

Different patterns of heparin resistance: therapeutic implications.

Marco Ranucci1, Giuseppe Isgrò, Anna Cazzaniga, Antonio Ditta, Alessandra Boncilli, Mauro Cotza, Giovanni Carboni, Simonetta Brozzi.   

Abstract

Heparin resistance (HR) during cardiac operations is a common feature. Its aetiology often recognizes a decrease in circulating antithrombin III (AT III) due to a preoperative heparin treatment. Nevertheless, some papers highlighted the existence of HR in patients with normal values of AT III. This paper was designed in order to identify this subgroup of AT III-independent heparin-resistant patients. Five hundred consecutive patients scheduled for coronary revascularization with cardiopulmonary bypass were enrolled in this prospective trial. HR was identified in 104 (20.8%) patients. Thirty-six of them (7.2% of the total population) had a preoperative AT III activity > or = 100%, and were defined as AT III-independent heparin-resistant patients. This subgroup significantly differs from the AT III-dependent heparin-resistant group being affected by a less severe degree of HR and including less patients pretreated with heparin. Unlike the other heparin-resistant patients, these subjects do not respond to AT III supplementation aimed at reaching supranormal AT III activity values.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12017388     DOI: 10.1191/0267659102pf562oa

Source DB:  PubMed          Journal:  Perfusion        ISSN: 0267-6591            Impact factor:   1.972


  17 in total

1.  Apparent heparin resistance in a patient with infective endocarditis secondary to elevated factor VIII levels.

Authors:  Ramya Thota; Apar Kishor Ganti; Shanmuga Subbiah
Journal:  J Thromb Thrombolysis       Date:  2012-07       Impact factor: 2.300

2.  Sudden Thrombosis in Coronary Artery Bypass Grafting Surgery.

Authors:  Bin Cheng; Jun-Sheng Mu; Jian-Qun Zhang; Ping Bo
Journal:  Chin Med J (Engl)       Date:  2015-10-20       Impact factor: 2.628

Review 3.  Heparin dose response is independent of preoperative antithrombin activity in patients undergoing coronary artery bypass graft surgery using low heparin concentrations.

Authors:  Sean Garvin; Daniel Fitzgerald; Jochen D Muehlschlegel; Tjörvi E Perry; Amanda A Fox; Stanton K Shernan; Charles D Collard; Sary Aranki; Simon C Body
Journal:  Anesth Analg       Date:  2010-02-08       Impact factor: 5.108

4.  Four cases of thrombotic events associated with neuro-endovascular therapy: heparin resistance and aspirin resistance.

Authors:  K Naito; H Nagashima; F Oya; J Koyama
Journal:  Interv Neuroradiol       Date:  2007-06-27       Impact factor: 1.610

5.  Heparin responsiveness during off-pump coronary artery bypass graft surgery: predictors and clinical implications.

Authors:  Duk-hee Chun; Seong-wan Baik; So Yeon Kim; Jae Kwang Shim; Jong Chan Kim; Young Lan Kwak
Journal:  Acta Pharmacol Sin       Date:  2010-12-06       Impact factor: 6.150

6.  Antithrombin Administration During Intravenous Heparin Anticoagulation in the Intensive Care Unit: A Single-Center Matched Retrospective Cohort Study.

Authors:  Jacob T Beyer; Kelly E Schoeppler; Giorgio Zanotti; Gregory M Weiss; Scott W Mueller; Robert MacLaren; Douglas N Fish; Tyree H Kiser
Journal:  Clin Appl Thromb Hemost       Date:  2016-09-13       Impact factor: 2.389

Review 7.  [Heparin resistance and antithrombin deficiency].

Authors:  Norbert Maurin
Journal:  Med Klin (Munich)       Date:  2009-06-16

8.  Heparin concentration-based anticoagulation for cardiac surgery fails to reliably predict heparin bolus dose requirements.

Authors:  Sean Garvin; Daniel C FitzGerald; George Despotis; Prem Shekar; Simon C Body
Journal:  Anesth Analg       Date:  2009-10-27       Impact factor: 5.108

9.  Antithrombin after cardiac surgery: implications on short and mid-term outcome.

Authors:  Domenico Paparella; Giangiuseppe Cappabianca; Giuseppe Scrascia; Giuseppe Fiore; Andreas Paramythiotis; Nicola Di Bari; Maria Pia Trisorio Liuzzi; Mohamed F Ibrahim; Tommaso Fiore; Luigi de Luca Tupputi Schinosa
Journal:  J Thromb Thrombolysis       Date:  2008-01-11       Impact factor: 2.300

10.  Heparin dose and postoperative bleeding in patients undergoing cardiopulmonary bypass.

Authors:  Mark W Rosin; David Holt
Journal:  J Extra Corpor Technol       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.